tetrahydrodiferuloylmethane hamilelikte güvenli mi?
No harmonised CLP classification or SCCS/CIR safety assessment specific to tetrahydrodiferuloylmethane was identified; peer-reviewed reviews of curcumin note limited and mixed reproductive data but do not establish human teratogenicity, and no specific developmental/teratology studies for topical tetrahydrocurcumin suitable to change the default. Topical use would likely give low but measurable systemic exposure. Sources: PubChem entry for tetrahydrocurcumin; ECHA registration/registration-dossier listing (no harmonised classification); reviews on curcumin and pregnancy. (PubChem; ECHA; PubMed).
Pregnancy-safe products containing tetrahydrodiferuloylmethane









Related ingredients
Frequently asked questions
- tetrahydrodiferuloylmethane hamilelikte güvenli mi?
- No harmonised CLP classification or SCCS/CIR safety assessment specific to tetrahydrodiferuloylmethane was identified; peer-reviewed reviews of curcumin note limited and mixed reproductive data but do not establish human teratogenicity, and no specific developmental/teratology studies for topical tetrahydrocurcumin suitable to change the default. Topical use would likely give low but measurable systemic exposure. Sources: PubChem entry for tetrahydrocurcumin; ECHA registration/registration-dossier listing (no harmonised classification); reviews on curcumin and pregnancy. (PubChem; ECHA; PubMed).
- tetrahydrodiferuloylmethane emzirirken güvenli mi?
- No evidence found that tetrahydrodiferuloylmethane is a known reproductive or lactation hazard and no harmonised or CIR/SCCS restrictions. Given topical application can lead to low systemic levels, breastfeeding exposure is plausibly low but measurable; no infant-specific data on excretion into milk was located. Sources cited below (ECHA registration listing, PubChem, curcumin pregnancy reviews).
- tetrahydrodiferuloylmethane bebek cildi için güvenli mi?
- No infant-specific toxicity data were located. Because infant skin has a higher surface-area-to-weight ratio and an immature barrier, exposure score is increased by +1 versus adult exposure (adult topical e=1 → infant e=2). No evidence found indicating specific developmental or dermatologic hazard to infants. Sources: PubChem, ECHA registration listing; reviews on curcumin safety.
- VeriMom tetrahydrodiferuloylmethane nasıl puanlıyor?
- VeriMom tetrahydrodiferuloylmethane'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tetrahydrodiferuloylmethane yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.